Parliament Workbench
Data: Official Report to 19 Nov 2026

Official Report · Chamber

Immunisation Programme

Tuesday 25 March 2014 Meeting of the Parliament Debate 17 contributions · 14 speakers Watch on Scottish Parliament TV

Speakers

Showing Michael Matheson only · show everyone

Michael Matheson’s contributions

3 contributions
Michael Matheson SNP The Minister for Public Health · Falkirk West
link

I am pleased to open the debate.

The World Health Organization has stated that the two public health interventions that have had the greatest impact on the world’s health are clean water and vaccines. Immunisation is one of the most effective ways of protecting the public against and reducing the spread of serious diseases.

The development of effective vaccines in the past few decades has led to a huge decline in the number of deaths from various diseases, particularly in childhood. Before the introduction of the national vaccination programme, Scottish children were extremely vulnerable to diseases such as whooping cough, polio and measles.

The Scottish routine childhood immunisation programme is one of the cornerstones of our efforts to improve and protect public health. Infants are vaccinated against a wide range of diseases that once posed a serious danger to life but are now condemned to the past. The programme has also dramatically reduced the incidence of once common diseases, such as tetanus, whooping cough, measles, mumps and rubella.

The immunisation programme’s value is very clear. For example, vaccination against measles was introduced in 1968. In 1970, more than 25,000 cases of measles were confirmed in Scotland. By 1994, the figure had fallen to 536 confirmed cases and, by 2012, that figure had declined further to just 28 confirmed cases.

Through the immunisation programme, we also offer important protection against conditions such as meningitis. Since 1999, children have been vaccinated against meningitis C as part of the routine childhood immunisation programme. When the vaccine was introduced, there were 95 cases of meningitis C; between 2008 and 2012 there were only 2 cases.

We have seen the effects of immunising our children against meningitis C, but meningitis B remains a greater threat. A vaccine against meningitis B became licensed for use last year, and the Joint Committee on Vaccination and Immunisation has just recommended its introduction in Scotland and across the rest of the United Kingdom. That is a major step forward in our ability to protect children from the threat of meningitis. I am sure that all members will welcome the decision to introduce the vaccination in the near future.

The importance of childhood immunisation programmes is recognised by the public, and Scotland has an enviably high uptake rate. For the past decade, Scotland has had uptake rates of between 96 per cent and 98 per cent for children completing the vaccination courses for diphtheria, tetanus, whooping cough, polio, meningococcal group C bacteria and pneumococcus by 24 months of age. That is consistently above the 95 per cent target that has been set by the World Health Organization. Uptake figures for other vaccination schedules, including the measles, mumps and rubella vaccination and the pneumococcal conjugate vaccine booster, are continuing to rise, too. The uptake rate for both of those is well above 90 per cent, and this year the uptake rate for the MMR vaccination reached the 95 per cent target.

Nevertheless, we cannot afford to be complacent. In 2013, Wales and England experienced a large outbreak of measles—a disease that has been targeted by the WHO for elimination in Europe by 2015. Unfortunately, MMR vaccine uptake declined to less than 80 per cent in Wales and England after the now-discredited Wakefield study, which resulted in an increased population susceptibility to measles. In Scotland, uptake of the MMR vaccine dropped to 87 per cent in 2003. The Scottish public health effort in response to that decline aimed to maximise uptake of MMR1 by the age of two, ensuring at least 95 per cent uptake of one dose of the MMR vaccine among children before they started school at the age of five. It then aimed to maximise uptake of the second dose of the MMR vaccine among children by the age of six.

The most recent uptake rate of the MMR vaccine in Scotland, for December 2013, was 96 per cent, and the uptake rate for MMR2 was almost 92 per cent. Overall, measles has been well controlled in Scotland, with only a small number of cases occurring sporadically across the country during 2013. Because uptake rates did not fall as sharply in Scotland as they did elsewhere in the UK following the Wakefield study, the effect of last year’s outbreak in Scotland was not as severe as the effect of the outbreak in England and Wales. Nevertheless, the children who were most vulnerable to that outbreak were those who would have been vaccinated in the late 1990s. For that reason, a short MMR vaccination catch-up programme was put in place to protect those children who were not vaccinated originally. The outbreak was an important reminder of the value of vaccination programmes and the speed with which a disease can spread if we do not remain vigilant.

Another long-running childhood immunisation programme that is delivering positive public health benefits is the human papillomavirus vaccination that is offered to girls in secondary 2. The programme protects girls against the two types of HPV that cause approximately 70 per cent of cervical cancer and two other types of HPV that cause 90 per cent of cases of genital warts. Since the introduction of the vaccination programme in September 2008, we have seen a consistently high uptake. Although we are only now seeing the results of the programme, research that will be published soon in the British Journal of Cancer will show that the high uptake rates have already led to a reduction in the prevalence of those types of HPV in young women.

Michael Matheson SNP The Minister for Public Health · Falkirk West
link

The member may be aware that the advice that Governments receive on the use of vaccination programmes comes from the Joint Committee on Vaccination and Immunisation. It is an issue to which the committee has given some consideration. Given some of the emerging data and information on the matter, the JCVI has set up a specialist sub-group to explore the issue further. Once that sub-group has reported to the committee and its report has been submitted to Government, we will be in a position to make an informed decision on the matter. At this point, we should allow that expert group to consider the existing body of evidence and then to evaluate how to take the matter forward effectively if the recommendation is that there should be changes to the HPV vaccination programme.

I do not have a timeframe that I can give the member, but I assure him that the process for carrying out the evaluation to which he refers is already in place.

It is not only in childhood that we have seen the value of immunisation. Since 2001, the seasonal influenza vaccination programme has offered protection to over-65s and those in at-risk groups. Consistently strong uptake rates since the introduction of the programme have meant that the number of deaths attributable to flu has almost halved; 2,000 fewer annual hospitalisations are caused by flu; and the number of consultations with general practitioners has fallen by a quarter.

Building on the success of the seasonal influenza programme, we have embarked on one of the most ambitious extensions to the immunisation programme. We know that children are vulnerable to the flu so, by extending the influenza programme to all children between the ages of two and 17, we will be able to offer important protection to those who are vaccinated. That is a significant undertaking, and the programme will be phased in over a number of years.

As well as protecting the children who are immunised, the benefits of the programme will extend into the population more generally, with yet further reductions in the number of deaths caused by influenza each year and in the number of hospitalisations and GP consultations that take place.

Last year, there was unprecedented expansion of the immunisation programme—there have been three new programmes over the past year alone. We have successfully implemented a vaccination programme against rotavirus, a disease that causes around 1,200 babies to be hospitalised each year. That comes alongside the introduction of the shingles vaccine and the childhood flu vaccination programme. Those programmes have been introduced in a way that allows the public to be assured about the ability to deliver major immunisation programmes in Scotland.

On the shingles vaccination programme, around 7,000 cases of shingles are recorded each year among people who are 70 years old. Since September 2013, people aged 70 have been offered vaccination against shingles, protecting them against what can be a long-term condition resulting in pain and discomfort.

The benefits of the immunisation programme that I have outlined are a reflection of the professionalism and expertise within the national health service in Scotland. None of it could have happened without the contribution of general practices, school nurses, NHS boards, Health Protection Scotland and other public agencies throughout the country, working together to ensure that Scotland’s vaccination programme functions successfully.

I move,

That the Parliament acknowledges the clear benefits and central importance of immunisation programmes to Scotland’s public health; commends Scotland’s high uptake rates for the adult and childhood programmes and, in particular, the average uptake rates of around 97% annually for routine childhood vaccinations, and supports the Scottish Government, Health Protection Scotland and other national agencies, NHS boards and GP practices in their commitment to these programmes.

15:54

Michael Matheson SNP The Minister for Public Health · Falkirk West
link

The debate has been very useful, and I am happy to say that we are happy to accept both the Labour and the Conservative Party amendments. The debate has been very helpful for the reasons that Nanette Milne outlined in her speech. Our national vaccination programmes are largely taken for granted, in that they happen and are very effective. They are programmes in which, if one element ever went wrong, that would very quickly become a major public health challenge and concern. That staff, particularly in our public health sector and primary care sector, have managed our vaccination programmes so successfully over many years is to their tremendous credit. We can rightfully be very proud of that.

As members have highlighted, the vaccination programmes extend from newborn babies right through to older members of our community. However, as a number of members said, they do not stand still. As a result of national and global vaccination programmes, we have seen the effective eradication of some conditions, such as smallpox, to which Richard Simpson referred, and polio, which has been eradicated in Europe since 2002. All those things are the result of good, effective immunisation and vaccination programmes. We are very lucky to have very safe and reliable vaccination programmes in Scotland that ensure that we can have confidence in how the process operates.

I want to pick up in particular the issue that Richard Simpson and Graeme Pearson highlighted: the concern about pressure on staff and the demands that the vaccination programmes place on them. I am acutely aware of the pressure that our staff are under in delivering the vaccination programmes, because I am extremely conscious that, in order to maintain public confidence in our immunisation programmes, we need to ensure that those programmes are robust and that they apply effectively the science for which they have been developed right across the country.

I will give members an illustration of the nature of some of the challenges that we face. An ever-increasing number of vaccinations have been introduced. A significant number of those vaccinations and immunisations are one-offs, or perhaps one, two or three immunisations are required at given times in a young person’s or older person’s life, but the flu vaccination programme must take place every single year. The introduction and extension of that programme to those between the ages of two and 17 almost overnight doubles the numbers in our childhood immunisation programme. That is a significant logistical challenge.

In order to deal with that challenge, in the first year we have used a number of different pilots in different health board areas to test out different approaches and to get staff feedback on which is the most appropriate. The pilots cover different age groups to find out what is the best approach for particular groups. For example, older kids can, under supervision, self-immunise in class. Other approaches are being taken with different age groups in primary schools, too. We are working with staff to identify the best way to proceed.

Another challenge is that we very often require the staff to undertake immunisation and vaccination programmes only for a short time over a given period during the year and not throughout the year. We will therefore introduce the programmes over a number of years. I know that some people want that to happen much quicker, but we should take our time to get it right and to work with the staff to ensure that we have a robust system and that the public can have confidence in the processes that we have in place.

Jackson Carlaw made an extremely important point. The approaches that we often take to different immunisation programmes are not a consequence of Government choice; rather, they are led by expert advice that is presented to Government. We react and respond to the expert advice that we receive, whether from the Joint Committee on Vaccination and Immunisation or from Health Protection Scotland. I am certainly not an expert in any shape or form, and in this area we are very much led by experts.

Richard Simpson mentioned a catch-up programme for kids who may have lost out by not having the MMR vaccine in the 1990s. Our approach is based on expert advice provided to ministers by Health Protection Scotland. If Health Protection Scotland believed that a different approach should be taken, I would be more than happy to take that approach. I reassure members that no complacency exists whatsoever. We are led by experts on the issue, and if the advice changes we will respond to that positively, for the very good reason that that is what we should do.

Graeme Pearson mentioned the shingles vaccination and the concerns expressed by some older people about whether they are entitled to that vaccination because of their age, and when they will be vaccinated. The introduction of that vaccination programme is based on JCVI advice. We will start off with people who have turned 70 and those who are 79, to catch them before they turn 80. Over the next three to four years, we will run a catch-up programme for those in between. I recognise that people may be concerned that they have not been vaccinated yet, but we are taking what the experts have recommended to us as the most robust approach. It is fair to say that there is limited availability of the shingles vaccine because only one manufacturer makes the vaccine. That is part of the reason for our roll-out programme.

I am also conscious that our vaccination programmes must be placed in the context of the international health agenda. Some members may be aware that the wild poliovirus was identified recently in Syria, which immediately resulted in advice from the World Health Organization: if a single case is identified in Europe, where polio has been eradicated, that will result in the release of oral polio vaccination stockpiles in Scotland.

We must take forward our vaccination and immunisation programmes in that global context. We must ensure that we have a robust system in place, so that can respond—in a safe and informed way—when new vaccines come along.

All members who spoke in the debate recognise that Scotland is well placed to build on the success of its vaccination programmes over recent years. This Government intends to build on that success, so that we gain the public health benefits that have come from having vaccination programmes in Scotland over the past several decades.

Motions, questions and votes

Linked from this item of the Official Report

No recorded division on these motions that day: decisions taken without a vote are not in the divisions feed.

  1. Time for Reflection Time for reflection · 2
  2. Stop and Search Questions · 12
  3. Independence (Currency Union) Questions · 11
  4. Young and Novice Drivers and Graduated Driver Licensing Debate · 34
  5. Immunisation Programme Debate · 17
  6. Decision Time Decision time · 10
  7. Asda Kirkcaldy Community Life Programme Members’ business · 6
  8. Correction Procedure · 2

The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.